Found 72 clinical trials
Comparison of OpeN VErsus RoboTic Partial Nephrectomy (CONVERT)
A prospective randomized controlled feasibility trial for patients undergoing partial nephrectomy for T1 renal masses at Princess Margaret. Participants will be randomized receive either open or
- 0 views
- 05 May, 2022
- 1 location
A Comparative Study Between Analgesic Effect of Opioid Free and Opioid Based Anesthesia in Radical Nephrectomy Surgery
Patients undergoing nephrectomy have a high incidence of postoperative pain. In the perioperative period, these patients are often treated with patient-controlled opioids, epidural analgesia, or
- 0 views
- 27 Apr, 2022
- 1 location
Auriculotherapy in the Treatment of Pre-Operative Anxiety
establish a superior correlation between the auriculotherapy treatment and the reduction of perioperative anxiety. Subject population will include those having a partial or total nephrectomy for cancer
- 0 views
- 22 Mar, 2022
- 1 location
3D Printing for Pre-Surgical Planning (3D)
nephrectomy. 2) Compare the accuracy of this innovative method for 3D printing to radiological images and pathological data when available.
- 0 views
- 24 Mar, 2022
- 2 locations
Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma
The specific aims of this study are: To determine the safety and feasibility of treating patients with a combination of MRI guided stereotactic body radiation therapy and microwave ablation. To assess short and long-term toxicity rates of patients treated with a combined modality approach. To assess local control, survival, and …
- 6 views
- 27 Jan, 2022
- 1 location
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
treatment of Clear Cell Renal Cell Carcinoma (ccRCC) post nephrectomy. The primary study hypothesis is that belzutifan plus pembrolizumab is superior to placebo plus pembrolizumab with respect to
- 0 views
- 17 May, 2022
- 39 locations
Anesthesia and Cancer Study: Renal Cell Carcinoma
This study investigates the influence of type of anesthesia on recurrence and survival of renal cell carcinoma in patients undergoing nephrectomy. The participants will be allocated to either
- 0 views
- 21 Mar, 2022
- 1 location
Renal Adjuvant MultiPle Arm Randomised Trial (RAMPART)
RATIONALE: The current global standard of care after nephrectomy for localised RCC therefore remains active monitoring (i.e., observation by clinical and radiological means). 30-40% patients
- 60 views
- 14 Feb, 2022
- 35 locations
Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations
nephrectomy. Study treatment is randomized 1:1 between infigratinib or placebo with treatment up to 1 year or until invasive local, distal, or metastatic disease recurrence confirmed by independent imaging
- 97 views
- 16 May, 2022
- 129 locations
89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study (89ZR-TLX250)
89Zr-TLX250 is under clinical development as a diagnostic agent targeting clear cell renal cell carcinoma.
- 33 views
- 09 Feb, 2022
- 30 locations